Description

3-Methyl-n-[(2E)-5-Methyl-1,3,4-Thiadiazol-2(3H)-Ylidene]-6,7-Dihydro-5H-Cyclopenta[B][1,2]Oxazolo[4,5-E]Pyridine-4-Carboxamide is a high-purity, complex heterocyclic organic compound designed for advanced research and development applications. Its intricate fused-ring structure makes it a valuable pharmacological intermediate and a key building block in medicinal chemistry. This compound is primarily utilized by pharmaceutical R&D teams and contract research organizations (CROs) focused on developing novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel active pharmaceutical ingredients (APIs) targeting various disease pathways.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Tool Compound: Used in in vitro assays to study specific enzyme inhibition or receptor modulation due to its unique heterocyclic architecture.
• Academic Research: Employed in university and institutional labs for investigating new organic synthesis methodologies and heterocyclic chemistry.
• Contract Manufacturing: Supplied to CDMOs for the cGMP or non-GMP production of development-stage drug candidates.
• Library Synthesis: A valuable building block for creating diverse compound libraries for high-throughput screening (HTS) in early-stage discovery.

Basic Information

Product Name	3-Methyl-n-[(2E)-5-Methyl-1,3,4-Thiadiazol-2(3H)-Ylidene]-6,7-Dihydro-5H-Cyclopenta[B][1,2]Oxazolo[4,5-E]Pyridine-4-Carboxamide
CAS No.	1179439-00-9
Molecular Formula	C16H15N5O2S
Molecular Weight	341.39 g/mol
Synonyms	3-Methyl-N-[(2E)-5-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-6,7-dihydro-5H-cyclopenta[b][1,2]oxazolo[4,5-e]pyridine-4-carboxamide; 3-Methyl-N-((E)-5-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-6,7-dihydro-5H-cyclopenta[b][1,2]oxazolo[4,5-e]pyridine-4-carboxamide; 1179439-00-9; Cyclopenta[b][1,2]oxazolo[4,5-e]pyridine-4-carboxamide, 6,7-dihydro-3-methyl-N-[(2E)-5-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-5H-; (2E)-3-Methyl-N-(5-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-6,7-dihydro-5H-cyclopenta[b][1,2]oxazolo[4,5-e]pyridine-4-carboxamide
EINECS	Contact for details

Quality Control

Our 3-Methyl-n-[(2E)-5-Methyl-1,3,4-Thiadiazol-2(3H)-Ylidene]-6,7-Dihydro-5H-Cyclopenta[B][1,2]Oxazolo[4,5-E]Pyridine-4-Carboxamide is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We support development with custom synthesis and analytical method development to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). This compound is moisture-sensitive (hygroscopic) and should be handled under an inert atmosphere for long-term stability. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.